What Is Accelerated Underwriting? A Guide for Life Insurance Carriers
Accelerated underwriting life insurance guide for carriers: adoption data, evidence sources, mortality outcomes, and the technology stack driving next-generation programs.
Accelerated underwriting in life insurance has evolved from an experimental program offered by a handful of early-adopting carriers into the dominant workflow model for individual life insurance in the United States. The accelerated underwriting life insurance guide that follows is written for carrier executives, actuaries, and underwriting leadership who need to understand not only what accelerated underwriting is, but where the practice stands in 2026, how the evidence base has matured, and what the next generation of programs looks like. According to Gen Re's 2025 U.S. Individual Life Next Gen Underwriting Survey---which collected data from 30 carriers representing over two million paid policies and $827 billion in volume---59 percent of individual life insurance applications now qualify for an accelerated underwriting path, up from 42 percent in 2021.
"Reducing time to issue is still the top AU workflow goal for most companies. Next came managing mortality slippage (45%) and increasing sales (41%)." --- Gen Re, 2025 Next Gen Underwriting Survey
How Accelerated Underwriting Works: A Life Insurance Carrier Perspective
Accelerated underwriting is not the absence of underwriting. It is the replacement of traditional evidence-gathering methods---primarily the paramedical examination and laboratory testing---with alternative data sources and algorithmic decision support that enable faster risk classification without proportional increases in mortality risk.
In a traditional underwriting workflow, every applicant above a threshold face amount undergoes a standardized evidence-gathering process: paramedical exam (vital signs, blood draw, urine collection), Attending Physician Statement (APS) ordering, prescription history check, motor vehicle report, and MIB check. This process typically takes 23 to 30 days from application to decision.
In an accelerated underwriting workflow, algorithmic triage determines which applicants can be evaluated using non-invasive evidence sources alone. Qualifying applicants bypass the paramedical exam entirely. Their risk classification is based on electronic health records, prescription histories, motor vehicle reports, MIB data, credit attributes, and---increasingly---contactless physiological measurement. The average accelerated decision is rendered in approximately 5 days, a reduction of 18 to 25 days compared to traditional underwriting.
The distinction between "accelerated" and "automated" is important. Accelerated underwriting means the evidence pathway is simplified, but a human underwriter may still review the case. Automated underwriting---also called straight-through processing---means the application is evaluated and decisioned entirely by algorithms without human intervention. According to Gen Re's 2025 data, only 12 percent of total applications are currently eligible for a fully automated path, while 47 percent qualify for accelerated (non-automated) underwriting.
| Characteristic | Traditional Underwriting | Accelerated Underwriting | Fully Automated Underwriting |
|---|---|---|---|
| Average time to decision | 23--30 days | ~5 days | Minutes to hours |
| Paramedical exam required | Yes | No | No |
| Fluid testing (blood, urine) | Yes | No | No |
| Human underwriter review | Always | Often (83% of AU cases) | No |
| Primary evidence sources | Exam, APS, labs, Rx, MVR, MIB | EHR, Rx, MVR, MIB, credit, contactless vitals | Same as accelerated, fully algorithmic |
| Share of total applications (2025) | 41% | 47% | 12% |
| Placement rate | 63% | 78% | 86% |
Applications: Where Carriers Are Deploying Accelerated Underwriting
Expanding Eligibility Criteria
The most consequential trend in accelerated underwriting is the expansion of eligibility to higher face amounts and older age bands. Programs that were originally limited to applicants under age 50 seeking coverage below $500,000 have been extended substantially. Some carriers now approve accelerated-eligible applications at face amounts as high as $5 million. This expansion is driven by growing confidence in alternative evidence sources---particularly EHR data, which provides a longitudinal medical history that in many cases is more comprehensive than the snapshot captured by a single paramedical exam.
Direct-to-Consumer and Embedded Distribution
Accelerated underwriting is an enabler of distribution model innovation. The direct-to-consumer life insurance channel, growing at a 6.75 percent CAGR through 2034, depends on seamless digital experiences. An applicant purchasing coverage through a mobile application expects a process measured in minutes, not weeks. Accelerated underwriting makes this possible. Similarly, embedded insurance distribution---where life coverage is offered within banking, mortgage, or employer platforms---requires underwriting workflows that operate at the speed of the host platform.
Supplementing Accelerated Evidence with Contactless Vitals
A structural challenge of accelerated underwriting is that waiving the paramedical exam also eliminates objective physiological measurement. The applicant's heart rate, blood pressure, and respiratory rate---data points that would have been captured during the exam---are absent from the accelerated file. Remote photoplethysmography (rPPG) addresses this gap. A 30-to-90-second facial video captured on the applicant's smartphone extracts heart rate, respiratory rate, heart rate variability, blood oxygen saturation, and blood pressure estimates, providing underwriters with physiological evidence without reintroducing the friction of an in-person exam.
Published research supports this application. A 2025 study published in Bioengineering demonstrated rPPG-derived pulse rate measurement with a mean absolute error of 1.061 bpm against ECG reference. A hospital-based study published in the Journal of Clinical Monitoring and Computing (2022) reported respiratory rate measurement with 96 percent agreement across 963 patients.
Group and Voluntary Benefits
Accelerated underwriting principles are extending beyond individual life into group and voluntary benefit programs. For employer-sponsored coverage, simplified issue and guarantee issue products have historically relied on limited evidence, often just age-based rate tables with minimal individual risk assessment. Carriers are exploring how accelerated underwriting techniques---prescription checks, EHR data, and contactless vitals---can enable more granular risk classification within group portfolios, potentially improving pricing accuracy without burdening certificate holders with invasive evidence requirements.
Research, Data, and Mortality Outcomes
The Gen Re Survey Series
Gen Re's survey program provides the most comprehensive longitudinal dataset on accelerated underwriting adoption and outcomes. The 2025 survey, released in December 2025, rebranded from "Accelerated Underwriting Survey" to "Next Gen Underwriting Survey," reflecting the evolution from a binary accelerated-or-traditional framework to a spectrum of evidence pathways adapted to individual applicant risk profiles.
Key findings from the 2025 survey:
- Eligibility growth: 59 percent of applications qualify for an accelerated path, up from 42 percent in 2021.
- Mortality slippage stabilization: Overall slippage improved to 12.3 percent in 2025 after several years of upward pressure. Two-thirds of companies estimate their slippage between 6 and 15 percent.
- Placement rate differential: Automated workflows achieve 86 percent placement, accelerated workflows achieve 78 percent, and traditional workflows achieve 63 percent.
- Program evolution: 65 percent of companies made material changes to their underwriting programs in the past 12 months.
EHR Adoption as a Foundation
Electronic health records have become the backbone of accelerated underwriting evidence. MIB data shows EHR release rates rising from 11 percent in 2020 to 52 percent in 2025 via HIPAA consent authorization, with 74 percent of records delivered in under 24 hours. Munich Re's 2024 analysis, combined with MIB data, documented how EHR availability correlates with accelerated underwriting program confidence and eligibility expansion. The Munich Re--MIB strategic partnership announced in May 2025 is specifically aimed at pushing EHR adoption beyond the current 52 percent release rate toward the 80 percent threshold that industry stakeholders identify as the inflection point for broad-based adoption.
NAIC Regulatory Engagement
The National Association of Insurance Commissioners has engaged with accelerated underwriting through multiple working groups. The Accelerated Underwriting (A) Working Group has been developing regulatory guidance addressing alternative evidence sources, algorithmic fairness, and consumer protection. The Big Data and Artificial Intelligence (H) Working Group completed its health insurance survey in 2025, finding that 58 percent of life insurers report current or planned AI usage. A model law on third-party data and models is anticipated in 2026, and state regulators are preparing an AI evaluation pilot program for the same year.
For carriers, the regulatory landscape is not a barrier but a framework under construction. The carriers that proactively build governance structures---model documentation, bias testing, consumer transparency---will be better positioned when formal requirements materialize.
The Future of Accelerated Underwriting
The trajectory of accelerated underwriting points toward what Gen Re describes as "Next Gen" underwriting: personalized evidence-gathering workflows that adapt dynamically to each applicant's risk profile rather than applying uniform rules based solely on age and face amount.
The automated tier will expand. Currently, only 12 percent of applications qualify for fully automated decisioning. As confidence in algorithmic risk classification grows---supported by the mortality slippage stabilization documented in 2025---carriers will extend automation eligibility. The 86 percent placement rate achieved by automated workflows provides a strong economic incentive.
Evidence integration will deepen. The underwriting technology stack is converging. EHR data, prescription histories, credit attributes, contactless physiological measurement, and behavioral signals are being ingested into unified decisioning engines that synthesize multiple data sources into composite risk assessments. LIMRA's forecast projects continued individual life insurance premium growth through 2026, creating market conditions that reward carriers who can underwrite efficiently at scale.
Contactless vitals will become standard. The physiological evidence gap in accelerated underwriting---the absence of vital sign data when the paramedical exam is waived---is a recognized limitation. rPPG technology addresses this gap directly. As the technology's robustness under real-world conditions continues to improve, and as supporting research studies accumulate, contactless vitals will transition from an emerging evidence source to a standard component of accelerated underwriting programs. The life insurance underwriting service market, projected to reach $50 billion by 2035, reflects the scale of investment flowing into these capabilities.
Mortality monitoring will mature. With 86 percent of Gen Re survey participants implementing or planning pre- and post-issue auditing, the feedback loop between underwriting decisions and claims outcomes will tighten. This data will enable continuous calibration of accelerated underwriting models, refining eligibility criteria and evidence requirements based on observed mortality experience rather than theoretical assumptions.
Frequently Asked Questions
What is the difference between accelerated underwriting and automated underwriting?
Accelerated underwriting simplifies the evidence pathway---waiving the paramedical exam and laboratory testing in favor of alternative data sources---but may still involve human underwriter review. Automated underwriting, also called straight-through processing, evaluates and decisions the application entirely through algorithms without human intervention. According to Gen Re's 2025 survey, 47 percent of applications qualify for accelerated underwriting while only 12 percent qualify for fully automated decisioning.
Does accelerated underwriting increase mortality risk for carriers?
Mortality slippage---the difference between expected and observed mortality in accelerated versus traditional cohorts---is the primary metric carriers monitor. Gen Re's 2025 survey reported that overall slippage improved to 12.3 percent, stabilizing after several years of upward pressure. Two-thirds of companies estimate their slippage between 6 and 15 percent. The trend suggests that the combination of richer alternative data sources and systematic post-issue auditing is enabling carriers to manage mortality risk effectively within accelerated programs.
What evidence sources replace the paramedical exam in accelerated underwriting?
Carriers typically combine electronic health records (52 percent release rate in 2025), prescription histories, motor vehicle reports, MIB data, and credit-based attributes. Increasingly, contactless physiological measurement via rPPG is being added to capture heart rate, respiratory rate, heart rate variability, and blood pressure estimates---vital sign data that would otherwise be absent when the paramedical exam is waived.
How does accelerated underwriting affect placement rates?
The data shows a strong correlation between underwriting speed and placement. Gen Re's 2025 survey found that applications processed through fully automated workflows achieved an 86 percent placement rate, compared to 78 percent through accelerated workflows and 63 percent through traditional underwriting. The 23-percentage-point gap between automated and traditional placement rates represents significant premium revenue that faster underwriting workflows can capture.
Accelerated underwriting has moved from experiment to industry standard. The next frontier is closing the physiological evidence gap. Circadify provides contactless vital sign measurement designed for integration into accelerated underwriting workflows, enabling carriers to capture objective health data without reintroducing the friction of a paramedical exam. Learn how contactless vitals strengthen your accelerated underwriting program.
